The Expression of Adipokines Vaspin and Chemerin in Pregnant Women with Gestational Diabetes
Mellitus

Abstract

Abstract:

Objective：To explore the relationships between the expression of visceral adipose tissue- derived serine protease
inhibitor（vaspin）and Chemerin in serum and visceral omental adipose tissue of pregnant women with gestational diabetes mellitus.
Methods：The levels of Vaspin and Chemerin in serum were measured by enzyme-linked immuno sorbent assay（ELISA）. Fasting
plasma glucose（FPG）, fasting insulin（FINS）, total cholesterol（TC）, triglyceride（TG）and c-reactive protein（CRP）were also
detected. The expression of Vaspin and Chemerin in visceral adipose tissue was detected by western blot. Results：Pregnant women
with GDM had higher insulin levels and insulin resistant（IR）than the healthy control group. Serum Vaspin and Chemerin levels were
found to be significantly increased in patients with GDM compared with healthy control subjects. Serum Chemerin levels were
positively associated with TC, TG and CRP, while Vaspin levels in serum were positively associated with body weight before pregnancy
and BMI at delivery, HDL, FINS and HOMA-IR. The expression levels of Chemerin in obese pregnant women obviously increased.
Conclusion: Vaspin and Chemerin are closely related to GDM risk factors, obesity and lipid metabolism disorders in pregnant women.

Key words: gestational diabetes mellitus, Vaspin, Chemerin, insulin resistance

CLC Number:

R714.256

Li Xiaohong, Chen Zhuo, Ma Runmei. The Expression of Adipokines Vaspin and Chemerin in Pregnant Women with Gestational Diabetes
Mellitus[J]. , 2017, 2(8): 44-48.

References

〔1〕程飞，郭晓蕙，杨慧霞. 妊娠糖尿病患者血清脂联素水平
及其临床意义〔J〕. 北京医学，2009，31（6）：337-339.
〔2〕杨慧霞，董悦，李苹，等. 妊娠期糖尿病孕妇的脂代谢变
化〔J〕. 中华围产医学杂志，1998，1（1）：19-21.
〔3〕CHEN X，SCHOLL T O，LESKIW M，et al. Differences in
maternal circulating fatty acid composition and dietary fat
intake in women with gestational diabetes mellitus or mild
gestation hyperglycemia〔J〕. Diabetes care，2010，33（9）：
2049-2054.
〔4〕POULOS S P，HAUSMAN D B，HAUSMAN A J.The devel?
opment and endocrine functions of adipose tissue〔J〕. Mo?
lecular and Cellular Endocrinology，2010，323（1）：20-34.
〔5〕GUSTAFSON B，ADIPOSE TISSUE. inflammation and ath?erosclerosis〔J〕. J Atherosclerosis and Thrombosis，2010，
17（4）：332-341.
〔6〕BOZAOGLU K，BOLTON K，MCMILLAN J，et al. Chemerin
is a novel adipokine associated with obesity and metabolic
syndrome〔J〕. Endocrinology，2007，148（10）：4687-4694.
〔7〕STEJSKAL D，KARPISEK M，HANULOVA Z，et al.
Chemerin is an independent marker of the metabolic syn?
drome in a Caucasian population- a pilot study〔J〕. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub，2008，
152（2）：217-221.
〔8〕MATTHEW C ERNST，MARK ISSA，KERRY B GORAL?
SKI，et al. Chemerin Exacerbates Glucose Intolerance in
Mouse Models of Obesity and Diabetes〔J〕. Endocrinology，
2010，151（5）：1998-2007.
〔9〕LAGO F，DIEGUEZ C，GTMEZ-REINO J，et al. Emerging
role of adipokines mediators of inflammation and immune
responses〔J〕. Cytokine Growth Factor Rev，2007，18（34）：
313-325.
〔10〕TAKAHASHI M，TAKAHASHI Y，TAKAHASHI K，et al.
Chemerin enhances insulin signaling and potentiates insu?
lin-stimulated glucose uptake in 3T3-L1 adipocytes〔J〕.
FEBS Lett，2008，582：573-578.
〔11〕BOZAOGLU K，BOLTON K，MCMILLAN J，et al. Chemer?
in is a novel adipokine associated with obesity and meta?
bolic syndrome〔J〕. Endocrinology，2012，97（4）：556-564.
〔12〕MATTHEW C ERNST，MARK ISSA，KERRY B，et al.
Chemerin Exacerbates Glucose Intolerance in Mouse Mod?
els of Obesity and Diabetes〔J〕. Endocrinology，2010，151
（5）：1998-2007.
〔13〕KLO TING N，BERNDT J，KRALISCH S，et al. Vaspin
gene expression in human adipose tissue：association with
obesity and type 2 diabetes〔J〕. Biochem Biophys Res
Commun，2006，339：430-436.
〔14〕YOUN B S，KLO TING N，KRATZSCH J，et al. Serum
Vaspin concentrations in human obesity and type 2 diabe?
tes〔J〕. Diabetes，2008，57：372-377.